Thanks Peach
Benitec Biopharma Limited (NASDAQ: BNTC), announced acceptance of five presentations at the 19th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT) being held in Washington D.C. on May 4-7, 2016.
Benitec Biopharma Limited (NASDAQ:BNTC) traded 50726 shares and its share price moved up 1.79% to close at $1.71. Benitec Biopharma Limited (NASDAQ:BNTC) quarterly performance is -51.14% while its year to date (YTD) performance is -57.46%.
- Forums
- ASX - By Stock
- a screaming buy
Thanks Peach Benitec Biopharma Limited (NASDAQ: BNTC), announced...
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online